Kentuckiana Medicine in Jeffersonvlle, IN - General Practice

Kentuckiana Medicine is a primary clinic (General Practice) in Jeffersonvlle, Indiana. The current practice location for Kentuckiana Medicine is 443 Spring St, Suite 303, Jeffersonvlle, Indiana. For appointments, you can reach them via phone at (812) 913-4416. The mailing address for Kentuckiana Medicine is 443 Spring St, Suite 303, Jeffersonvlle, Indiana and phone number is (812) 913-4416.

Kentuckiana Medicine is licensed to practice in * (Not Available) (license number ) and its NPI number is 1104229426. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (812) 913-4416.

Contact Information

	Kentuckiana Medicine
	443 Spring St Suite 303 Jeffersonvlle IN 47130-4494
	(812) 913-4416
	(812) 213-8408

Primary Care Clinic Profile

Full Name	Kentuckiana Medicine
Speciality	General Practice
Location	443 Spring St, Jeffersonvlle, Indiana
Authorized Official Name and Position	Rafael F Cruz (OWNER)
Authorized Official Contact	8594685065
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Kentuckiana Medicine 443 Spring St Suite 303 Jeffersonvlle IN 47130-4494 Ph: (812) 913-4416	Kentuckiana Medicine 443 Spring St Suite 303 Jeffersonvlle IN 47130-4494 Ph: (812) 913-4416

NPI Details:

NPI Number	1104229426
Provider Enumeration Date	10/01/2014
Last Update Date	10/01/2014

Medical Identifiers

Medical identifiers for Kentuckiana Medicine such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1104229426	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	(* (Not Available))	Primary

News Archive

Bruker receives Health Canada approval for IVD MALDI Biotyper

At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases, the companies i2A Canada and Bruker Ltd. announced together that they have met the relevant Health Products and Food Branch of Health Canada regulations for the Bruker IVD MALDI Biotyper, and that this product is now available for sale as a Class 1 Medical Device to all clinical microbiology sites in Canada.

Improved gene editing technique can successfully cut out undesirable genetic information

City of Hope researchers may have found a way to sharpen the fastest, cheapest and most accurate gene editing technique, CRISPR-Cas9, so that it can more successfully cut out undesirable genetic information.

Nonsurgical treatment options effective for sufferers of chronic rhinosinusitis

For sufferers of chronic rhinosinusitis, surgery is often the only treatment option due to the severity of their condition.

South African TB Conference hears demands from advocacy organizations to improve, decentralize treatment

The 2012 South African TB Conference opened Tuesday night in Durban, with the Treatment Action Campaign, Section27, and Oxfam delivering "a memorandum containing five demands to conference organizers shortly before the opening," health-e News Service reports.

Kentuckiana Medicine - Primary Care in Jeffersonvlle, IN